The European Pharmacopoeia is preparing for 2021 while also supporting the industry to develop vaccines and treatments for COVID-19. Microgen - Stock.adobe.com The race for the development and ...
Updates to Ph. Eur. include validated tests for N-nitrosamine impurities in sartan APIs. Vielle (EDQM): The new chapter ‘Test for bacterial endotoxins using recombinant factor C’ (2.6.32) describes a ...
“EDQM may, therefore, block applications at receipt from May 2024 in case these are considered deficient to start the assessment process.” The directorate published the updated guideline days before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback